ORIGINAL RESEARCH
Published on 21 May 2024
Synergistic antitumor immune response mediated by paclitaxel-conjugated nanohybrid oncolytic adenovirus with dendritic cell therapy
doi 10.3389/fimmu.2024.1355566
- 1,164 views
- 1 citation
- Frontiers in Immunology
- Cancer Immunity and Immunotherapy
- Research Topics
- Vector-based Cancer Immunotherapy
Vector-based Cancer Immunotherapy
9,368
Total Downloads
31k
Total Views and Downloads
Submit your idea
Select the journal/section where you want your idea to be submitted:
Articles
ORIGINAL RESEARCH
Published on 15 May 2024
Tumor microenvironment-modulating oncolytic adenovirus combined with GSK-3β inhibitor enhances antitumor immune response against bladder cancer
doi 10.3389/fimmu.2024.1360436
- 1,667 views
ORIGINAL RESEARCH
Published on 15 Mar 2024
Riboswitch-controlled IL-12 gene therapy reduces hepatocellular cancer in mice
doi 10.3389/fimmu.2024.1360063
- 2,175 views
- 4 citations
REVIEW
Published on 22 Feb 2024
Revolutionizing cancer treatment: the power of bi- and tri-specific T-cell engagers in oncolytic virotherapy
doi 10.3389/fimmu.2024.1343378
- 3,579 views
- 3 citations
REVIEW
Published on 12 Jan 2024
Oncolytic vaccinia virus and cancer immunotherapy
doi 10.3389/fimmu.2023.1324744
- 5,691 views
- 7 citations
CORRECTION
Published on 19 Dec 2023
Corrigendum: Advances in oncolytic herpes simplex virus and adenovirus therapy for recurrent glioma
doi 10.3389/fimmu.2023.1352909
- 536 views
REVIEW
Published on 01 Dec 2023
Advances in tumor immunomodulation based on nanodrug delivery systems
doi 10.3389/fimmu.2023.1297493
- 1,479 views
- 4 citations
ORIGINAL RESEARCH
Published on 20 Nov 2023
Novel combinatorial therapy of oncolytic adenovirus AdV5/3-D24-ICOSL-CD40L with anti PD-1 exhibits enhanced anti-cancer efficacy through promotion of intratumoral T-cell infiltration and modulation of tumour microenvironment in mesothelioma mouse model
doi 10.3389/fonc.2023.1259314
- 2,148 views
- 2 citations
REVIEW
Published on 02 Nov 2023
Advances in oncolytic herpes simplex virus and adenovirus therapy for recurrent glioma
doi 10.3389/fimmu.2023.1285113
- 2,919 views
- 6 citations
MINI REVIEW
Published on 30 Mar 2023
mRNA melanoma vaccine revolution spurred by the COVID-19 pandemic
doi 10.3389/fimmu.2023.1155728
- 5,262 views
- 6 citations
Published in
Frontiers in Immunology
- Cancer Immunity and Immunotherapy
Participating Journals
Frontiers in Oncology
- 3.5 impact factor
- 6.2 citescore
Impact
- 31kTopic views
- 21kArticle views
- 9,368Article downloads